2 h. ago 'Buy' BHEL Shares Maintains ICICI Securities On Improving Fundamentals

ICICI Securities cites improving fundamentals, strong order inflows, and execution ramp-up as key drivers for the upgrade.

Politics

5 h. ago ITC Hotels Gets 'Buy' Rating As ICICI Securities Initiates Coverage Amid Expansion Plans; Sees 21% Upside

ITC Hotels aims to scale up to 220 hotels and 20,000+ keys by 2030, driven by its 'asset-right' strategy, which emphasizes managed properties for capital-efficient growth.

Politics

6 d. ago ICICI Securities Maintains 'Add' On Mindspace REIT; Sees Rs 2,920 Crore Acquisition To Drive Value

Mindspace REIT's Rs 2,920 crore acquisition of prime Mumbai and Pune assets is expected to boost NOI by 9% and DPU by 1.7%.

Politics

9 d. ago Mindspace REIT Buys Office Spaces In Mumbai, Pune For Rs 2,916 Crore

Ramesh Nair, MD and CEO of Mindspace REIT, said, 'Bringing these assets into the Mindspace REIT portfolio is a strategic step in strengthening our presence in Mumbai's most sought-after CBD office...

Politics

1 week ago 'Buy' Premier Energies Shares Maintains ICICI Securities Citing Strong Industry Tailwinds

ICICI Securities maintains 'Buy' rating on Premier Energies, sees upto 33% upside, details inside.

Politics

1 week ago Travel Food Services Gets Bullish Nod As ICICI Securities Initiates 'Buy'

The company operates in the travel quick-service restaurants space and lounge sectors in airports.

Politics

3 w. ago ICICI Securities Maintains 'Buy' On Sun TV Shares On Inexpensive Valuations; Sees 29% Upside

Given Sun's inexpensive valuations, the stock is likely to re-rate once there are signs of recovery in ad revenue; hence, ICICI Securities maintains 'Buy'.

Politics

3 w. ago Granules India Q2 Review: Dolat Capital Maintains 'Add', Hikes Target Price

Any escalation of the warning letter on the Gagillapur facility to an import alert will lead to a downgrade in its earnings and rating, adds Dolat Capital.

Events

3 w. ago Alkem Labs Q2 Review: Dolat Capital Upgrades EPS Estimate For FY26

Dolat Capital upgrades Alkem Labs' FY26E/FY27E EPS estimates by 3.5%/6.0%, assuming higher sales and Ebitda margin.

Politics